Skip to main content
Erschienen in: World Journal of Surgery 6/2014

01.06.2014

Surgical Treatment of Patients with Mildly Elevated Parathormone and Calcium Levels

verfasst von: Punam P. Parikh, Bassan J. Allan, John I. Lew

Erschienen in: World Journal of Surgery | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Patients with mildly elevated parathormone (PTH) and calcium levels consistent for primary hyperparathyroidism (pHPT) may present with more underlying multiglandular disease (MGD) and higher operative failure and recurrence rates than those with conventional, or “classic” pHPT. This study compared the clinical characteristics and surgical outcomes of patients with biochemically mild versus conventional pHPT.

Methods

A series of 707 consecutive patients underwent initial targeted parathyroidectomy with intraoperative parathormone monitoring (IPM) at a single institution. Biochemically mild (BM) pHPT was defined as PTH > 65 and <100 pg/ml with serum calcium >10.4 and <11 mg/dl. Conventional pHPT was defined as calcium ≥11 mg/dl and PTH ≥ 100 pg/ml. Prospectively collected data for all patients, including operative indication, preoperative laboratory values, imaging, IPM dynamics, and postoperative laboratory values were retrospectively reviewed. Additional assessments included presence of MGD, bilateral neck exploration (BNE), single-gland volume, and operative failure or success, and recurrence.

Results

Of 60 patients with BM-pHPT, 46 reported preoperative bone pain, kidney stones, fatigue, and/or mental disturbances. The remaining 14 BM-pHPT patients underwent parathyroidectomy based on published asymptomatic guidelines. Patients with BM-pHPT had significantly more kidney stones, MGD, and BNE. Average single-gland volume and postoperative PTH levels were significantly lower in BM-pHPT patients. There were no significant differences between groups regarding preoperative localization accuracy, IPM dynamics, or operative success/failure, recurrence rates.

Conclusions

BM-pHPT patients had more MGD requiring BNE but achieved operative success rates similar to those of patients with conventional disease. IPM successfully identifies MGD in BM-pHPT patients, who should be counseled regarding more extensive operations than limited parathyroidectomy.
Literatur
1.
Zurück zum Zitat Esselstyn CB Jr, Crile G Jr (1970) Hyperparathyroidism—epidemic or endemic? Diagnosis and treatment. Clevel Clin Q 37:87–91CrossRef Esselstyn CB Jr, Crile G Jr (1970) Hyperparathyroidism—epidemic or endemic? Diagnosis and treatment. Clevel Clin Q 37:87–91CrossRef
2.
3.
Zurück zum Zitat Boonstra CE, Jackson CE (1971) Serum calcium: survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Pathol 55:523–526PubMed Boonstra CE, Jackson CE (1971) Serum calcium: survey for hyperparathyroidism: results in 50,000 clinic patients. Am J Clin Pathol 55:523–526PubMed
4.
Zurück zum Zitat Preisman RA, Mehnert JH (1971) A plethora of primary hyperparathyroidism. Arch Surg 103:12–13PubMedCrossRef Preisman RA, Mehnert JH (1971) A plethora of primary hyperparathyroidism. Arch Surg 103:12–13PubMedCrossRef
5.
Zurück zum Zitat Britton DC, Johnston IDA, Thompson MH et al (1973) The outcome of treatment and changes in presentation of primary hyperparathyroidism. Br J Surg 60:782–785PubMedCrossRef Britton DC, Johnston IDA, Thompson MH et al (1973) The outcome of treatment and changes in presentation of primary hyperparathyroidism. Br J Surg 60:782–785PubMedCrossRef
6.
Zurück zum Zitat Barzel US (1977) The changing face of hyperparathyroidism. Hosp Pract 12(11):89–94PubMed Barzel US (1977) The changing face of hyperparathyroidism. Hosp Pract 12(11):89–94PubMed
7.
Zurück zum Zitat Christensson T (1976) Familial hyperparathyroidism. Ann Interm Med 85:614–615CrossRef Christensson T (1976) Familial hyperparathyroidism. Ann Interm Med 85:614–615CrossRef
8.
Zurück zum Zitat Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335–339PubMedCentralPubMedCrossRef Bilezikian JP, Khan AA, Potts JT Jr (2009) Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metab 94:335–339PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Amin AL, Wang TS, Wade TJ et al (2011) Normal PTH levels in primary hyperparathyroidism: still the same disease? Ann Surg Oncol 18:3437–3442PubMedCrossRef Amin AL, Wang TS, Wade TJ et al (2011) Normal PTH levels in primary hyperparathyroidism: still the same disease? Ann Surg Oncol 18:3437–3442PubMedCrossRef
10.
Zurück zum Zitat Clark JM, Pellitteri PK (2009) Assessing the impact of low baseline parathyroid hormone levels on surgical treatment of primary hyperparathyroidism. Laryngoscope 119:1100–1105PubMedCrossRef Clark JM, Pellitteri PK (2009) Assessing the impact of low baseline parathyroid hormone levels on surgical treatment of primary hyperparathyroidism. Laryngoscope 119:1100–1105PubMedCrossRef
11.
Zurück zum Zitat Miller BS, England BG, Nehs M et al (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery 140:883–890PubMedCrossRef Miller BS, England BG, Nehs M et al (2006) Interpretation of intraoperative parathyroid hormone monitoring in patients with baseline parathyroid hormone levels of <100 pg/mL. Surgery 140:883–890PubMedCrossRef
12.
Zurück zum Zitat Kebebew E, Hwang J, Duh QY et al (2006) Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 141:777–782PubMedCrossRef Kebebew E, Hwang J, Duh QY et al (2006) Predictors of single-gland vs multigland parathyroid disease in primary hyperparathyroidism: a simple and accurate scoring model. Arch Surg 141:777–782PubMedCrossRef
13.
Zurück zum Zitat Adler JT, Sippel RS, Schaefer S et al (2009) Surgery improves quality of life in patients with “mild” hyperparathyroidism. Am J Surg 197:284–290PubMedCrossRef Adler JT, Sippel RS, Schaefer S et al (2009) Surgery improves quality of life in patients with “mild” hyperparathyroidism. Am J Surg 197:284–290PubMedCrossRef
16.
Zurück zum Zitat Irvin GL, Deriso GT (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468PubMedCrossRef Irvin GL, Deriso GT (1994) A new, practical intraoperative parathyroid hormone assay. Am J Surg 168:466–468PubMedCrossRef
18.
Zurück zum Zitat Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186–190PubMedCrossRef Westerdahl J, Lindblom P, Bergenfelz A (2002) Measurement of intraoperative parathyroid hormone predicts long-term operative success. Arch Surg 137:186–190PubMedCrossRef
19.
Zurück zum Zitat Irvin GL, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708PubMedCentralPubMedCrossRef Irvin GL, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708PubMedCentralPubMedCrossRef
20.
Zurück zum Zitat Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478PubMedCrossRef Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478PubMedCrossRef
21.
Zurück zum Zitat Chen H, Pruhs Z, Starling JR et al (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–590PubMedCrossRef Chen H, Pruhs Z, Starling JR et al (2005) Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138:583–590PubMedCrossRef
22.
Zurück zum Zitat Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343PubMedCrossRef Greene AB, Butler RS, McIntyre S et al (2009) National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 209:332–343PubMedCrossRef
23.
Zurück zum Zitat Hathaway TD, Gareth J, Stechman M et al (2012) The value of intraoperative PTH measurements in patients with mild primary hyperparathyroidism. Arch Surg 398:723–727CrossRef Hathaway TD, Gareth J, Stechman M et al (2012) The value of intraoperative PTH measurements in patients with mild primary hyperparathyroidism. Arch Surg 398:723–727CrossRef
24.
Zurück zum Zitat Irvin GL, Carneiro DM (2000) Management changes in primary hyperparathyroidism. JAMA 284:934–936PubMedCrossRef Irvin GL, Carneiro DM (2000) Management changes in primary hyperparathyroidism. JAMA 284:934–936PubMedCrossRef
25.
Zurück zum Zitat Ito F, Sippel R, Lederman J et al (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963PubMedCentralPubMedCrossRef Ito F, Sippel R, Lederman J et al (2007) The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245:959–963PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Biertho LD, Kim C, Wu HS et al (2004) Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 199:229–233PubMedCrossRef Biertho LD, Kim C, Wu HS et al (2004) Relationship between sestamibi uptake, parathyroid hormone assay, and nuclear morphology in primary hyperparathyroidism. J Am Coll Surg 199:229–233PubMedCrossRef
27.
Zurück zum Zitat Rutledge R, Stiegel M, Thomas CGJ et al (1985) The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 98:1107–1112PubMed Rutledge R, Stiegel M, Thomas CGJ et al (1985) The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 98:1107–1112PubMed
28.
Zurück zum Zitat Mozes G, Curlee KJ, Rowland CM et al (2002) The predictive value of laboratory findings in patients with primary hyperparathyroidism. J Am Coll Surg 194:126–130PubMedCrossRef Mozes G, Curlee KJ, Rowland CM et al (2002) The predictive value of laboratory findings in patients with primary hyperparathyroidism. J Am Coll Surg 194:126–130PubMedCrossRef
29.
Zurück zum Zitat Moretz WH, Watts TL, Virgin FW et al (2007) Correlation of intraoperative parathyroid hormone levels with parathyroid gland size. Laryngoscope 117:1957–1960PubMedCrossRef Moretz WH, Watts TL, Virgin FW et al (2007) Correlation of intraoperative parathyroid hormone levels with parathyroid gland size. Laryngoscope 117:1957–1960PubMedCrossRef
Metadaten
Titel
Surgical Treatment of Patients with Mildly Elevated Parathormone and Calcium Levels
verfasst von
Punam P. Parikh
Bassan J. Allan
John I. Lew
Publikationsdatum
01.06.2014
Verlag
Springer US
Erschienen in
World Journal of Surgery / Ausgabe 6/2014
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-014-2487-1

Weitere Artikel der Ausgabe 6/2014

World Journal of Surgery 6/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.